Moss Genomics

Moss Genomics is a disrupter in the Biotechnology and Health Care industries, providing personalized health and gut health solutions utilizing genomic, microbiome, and epigenome data. Founded in 2018, Moss is at the forefront of consumer healthcare, offering a comprehensive line of probiotics and nutritional supplements tailored to individual needs. The company's slogan, "Moss offers personalized health, anti-aging and wellness offerings guided by genomic, microbiome, and epigenome data," encapsulates its innovative approach to improving overall well-being. Although specific headquarters and last investment details are currently unavailable, Moss Genomics' pioneering vision and commitment to leveraging cutting-edge technology in the healthcare sector position it as an intriguing prospect for potential venture capital investment.